Skip to main content

NUsurface addresses the current unmet clinical need for those with early knee osteoarthritis who are too old for meniscal allograft transplantation—yet are too young for, or are unwilling to have, total knee arthroplasty.

MEET SARAH, THE “FORGOTTEN MIDDLE.”

She thought that her knee was fixed.

Sarah, a 45-year-old, had arthroscopic meniscus surgery 3 years ago. It was scoped, trimmed, and supposedly fixed.

But here’s what nobody tells you about meniscus surgery: It’s not a fix. It’s just a delay. You remove the problem in the short term, but eventually, the pain returns.

READDRESSING THE PROBLEM.

Sarah's pain returned. She visited her orthopedic surgeon, hoping for options.

Sarah is diagnosed with post-meniscectomy knee pain, and her MRI confirmed the diagnosis, confirming a meniscus-deficient knee.

The verdict that defines medical helplessness: “Your cartilage is too healthy for knee replacement. Sorry.”

Sarah is trapped in orthopedic treatment purgatory. She may be too old for biologic treatment options— yet does not want, or is too young for, a knee replacement.

“Sarah can now get pain relief as early as six weeks after the procedure.”

A NEW HOPE.

We can offer hope to those patients stuck in this critical treatment gap.

NUsurface solves this problem by offering a bridging procedure that can help patients return to the important activities of daily living with a lot less pain and suffering all the while, protecting the cartilage of their knee.

Over 15 years and four clinical trials, NUsurface has generated remarkable data.

We have seen a consistent signal of pain relief starting as early as six weeks post-op, with outcomes followed out to 5-years.

In the real world, our first patient is still going strong 15 years after surgery. This has allowed him to stay in the marching band of his Italian town and to live on the third floor of his elevator-less apartment.